Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study
- PMID: 18786637
- DOI: 10.1016/j.nbd.2008.08.001
Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study
Abstract
[11C](R)PK11195-PET is a marker of activated microglia while [11C]PIB-PET detects raised amyloid load. Here we studied in vivo the distributions of amyloid load and microglial activation in Alzheimer's disease (AD) and their relationship with cognitive status. Thirteen AD subjects had [11C](R)PK11195-PET and [11C]PIB-PET scans. Ten healthy controls had [11C](R)PK11195-PET and 14 controls had [11C]PIB-PET scans. Region-of-interest analysis of [11C](R)PK11195-PET detected significant 20-35% increases in microglial activation in frontal, temporal, parietal, occipital and cingulate cortices (p<0.05) of the AD subjects. [11C]PIB-PET revealed significant two-fold increases in amyloid load in these same cortical areas (p<0.0001) and SPM (statistical parametric mapping) analysis confirmed the localisation of these increases to association areas. MMSE scores in AD subjects correlated with levels of cortical microglial activation but not with amyloid load. The inverse correlation between MMSE and microglial activation is compatible with a role of microglia in neuronal damage.
Similar articles
-
Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.Neurology. 2007 Feb 13;68(7):501-8. doi: 10.1212/01.wnl.0000244749.20056.d4. Epub 2006 Oct 25. Neurology. 2007. PMID: 17065593
-
An early and late peak in microglial activation in Alzheimer's disease trajectory.Brain. 2017 Mar 1;140(3):792-803. doi: 10.1093/brain/aww349. Brain. 2017. PMID: 28122877 Free PMC article.
-
Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease.Arch Neurol. 2009 Jan;66(1):60-7. doi: 10.1001/archneurol.2008.511. Arch Neurol. 2009. PMID: 19139300 Free PMC article.
-
Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer's disease.Brain. 2017 Jul 1;140(7):2002-2011. doi: 10.1093/brain/awx120. Brain. 2017. PMID: 28575151
-
Imaging microglial activation in Huntington's disease.Brain Res Bull. 2007 Apr 30;72(2-3):148-51. doi: 10.1016/j.brainresbull.2006.10.029. Epub 2006 Nov 27. Brain Res Bull. 2007. PMID: 17352938 Review.
Cited by
-
Deciphering the mechanism underlying late-onset Alzheimer disease.Nat Rev Neurol. 2013 Jan;9(1):25-34. doi: 10.1038/nrneurol.2012.236. Epub 2012 Nov 27. Nat Rev Neurol. 2013. PMID: 23183882 Review.
-
Association between air pollution and CSF sTREM2 in cognitively normal older adults: The CABLE study.Ann Clin Transl Neurol. 2022 Nov;9(11):1752-1763. doi: 10.1002/acn3.51671. Epub 2022 Oct 31. Ann Clin Transl Neurol. 2022. PMID: 36317226 Free PMC article.
-
Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.Adv Pharmacol. 2012;64:27-81. doi: 10.1016/B978-0-12-394816-8.00002-7. Adv Pharmacol. 2012. PMID: 22840744 Free PMC article. Review.
-
Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical Use.CNS Drugs. 2015 Apr;29(4):313-30. doi: 10.1007/s40263-015-0237-z. CNS Drugs. 2015. PMID: 25948171 Review.
-
Local Sleep and Alzheimer's Disease Pathophysiology.Front Neurosci. 2020 Sep 23;14:525970. doi: 10.3389/fnins.2020.525970. eCollection 2020. Front Neurosci. 2020. PMID: 33071726 Free PMC article. Review.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical